Investigator
Samirkumar Patel
MOONLIGHT THERAPEUTICS, INC. · funded by NIAID
- Companies
- 3
- Grants
- 4
- Non-dilutive funding
- $4.0M
- First award
- May 6, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 2, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MOONLIGHT THERAPEUTICS, INC.Momentum in another area
ImmunologyGrant-only
- MOONLIGHT THERAPEUTICS, INC.Momentum in another area
ImmunologyGrant-only
- MOONLIGHT THERAPEUTICS, INC.Momentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U44
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
$1000kJun 2, 2025NIAIDMOONLIGHT THERAPEUTICS, INC.NIH RePORTER · 11305456 (opens the source filing in a new tab)
- U44
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
$1000kJun 2, 2025NIAIDMOONLIGHT THERAPEUTICS, INC.NIH RePORTER · 11346046 (opens the source filing in a new tab)
- SB1
Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
$998kMay 6, 2024NIAIDMOONLIGHT THERAPEUTICS, INC.NIH RePORTER · 11084470 (opens the source filing in a new tab)
- SB1
Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
$999kMay 6, 2024NIAIDMOONLIGHT THERAPEUTICS, INC.NIH RePORTER · 11326335 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources